-
1
-
-
84904643448
-
-
Academic Press, Inc., California
-
Bucala CA. Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging. Academic Press, Inc., California, 1992.
-
(1992)
Advanced Glycosylation: Chemistry, Biology, and Implications for Diabetes and Aging
-
-
Bucala, C.A.1
-
2
-
-
0023950461
-
Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
-
Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med., 318, 1315-1321 (1988).
-
(1988)
N. Engl. J. Med.
, vol.318
, pp. 1315-1321
-
-
Brownlee, M.1
Cerami, A.2
Vlassara, H.3
-
3
-
-
0030512148
-
Advanced glycation end-products in diabetic nephropathy
-
Sugiyama S, Miyata T, Horie K, Iida Y, Tsuyuki M, Tanaka H, Maeda K. Advanced glycation end-products in diabetic nephropathy. Nephrol. Dial. Transplant., 11 (Suppl. 5), 91-94 (1996).
-
(1996)
Nephrol. Dial. Transplant.
, vol.11
, Issue.SUPPL. 5
, pp. 91-94
-
-
Sugiyama, S.1
Miyata, T.2
Horie, K.3
Iida, Y.4
Tsuyuki, M.5
Tanaka, H.6
Maeda, K.7
-
4
-
-
11144324314
-
Advanced glycation endproducts-role in pathology of diabetic complications
-
Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res. Clin. Pract., 67, 3-21 (2005).
-
(2005)
Diabetes Res. Clin. Pract.
, vol.67
, pp. 3-21
-
-
Ahmed, N.1
-
5
-
-
0035227858
-
Pharmaceutical intervention of advanced glycation endproducts
-
discussion, 212-216, 217-220
-
Cerami A, Ulrich P. Pharmaceutical intervention of advanced glycation endproducts. Novartis Found. Symp., 235, 202-212, discussion, 212-216, 217-220 (2001).
-
(2001)
Novartis Found. Symp.
, vol.235
, pp. 202-212
-
-
Cerami, A.1
Ulrich, P.2
-
6
-
-
21444449221
-
The role of AGEs and AGE inhibitors in diabetic cardiovascular disease
-
Thomas MC, Baynes JW, Thorpe SR, Cooper ME. The role of AGEs and AGE inhibitors in diabetic cardiovascular disease. Curr. Drug Targets, 6, 453-474 (2005).
-
(2005)
Curr. Drug Targets
, vol.6
, pp. 453-474
-
-
Thomas, M.C.1
Baynes, J.W.2
Thorpe, S.R.3
Cooper, M.E.4
-
7
-
-
0022644227
-
Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking
-
Brownlee M, Vlassara H, Kooney A, Ulrich P, Cerami A. Aminoguanidine prevents diabetes-induced arterial wall protein crosslinking. Science, 232, 1629-1632 (1986).
-
(1986)
Science
, vol.232
, pp. 1629-1632
-
-
Brownlee, M.1
Vlassara, H.2
Kooney, A.3
Ulrich, P.4
Cerami, A.5
-
8
-
-
0142074864
-
Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts
-
Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Arch. Biochem. Biophys., 419, 31-40 (2003).
-
(2003)
Arch. Biochem. Biophys.
, vol.419
, pp. 31-40
-
-
Thornalley, P.J.1
-
9
-
-
0035172601
-
Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links
-
Vasan S, Foiles PG, Founds HW. Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links. Expert Opin. Investig. Drugs, 10, 1977-1987 (2001).
-
(2001)
Expert Opin. Investig. Drugs
, vol.10
, pp. 1977-1987
-
-
Vasan, S.1
Foiles, P.G.2
Founds, H.W.3
-
10
-
-
0035970120
-
A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys
-
Vaitkevicius PV, Lane M, Spurgeon H, Ingram DK, Roth GS, Egan JJ, Vasan S, Wagle DR, Ulrich P, Brines M, Wuerth JP, Cerami A, Lakatta EG. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc. Natl. Acad. Sci. U.S.A., 98, 1171-1175 (2001).
-
(2001)
Proc. Natl. Acad. Sci. U.S.A.
, vol.98
, pp. 1171-1175
-
-
Vaitkevicius, P.V.1
Lane, M.2
Spurgeon, H.3
Ingram, D.K.4
Roth, G.S.5
Egan, J.J.6
Vasan, S.7
Wagle, D.R.8
Ulrich, P.9
Brines, M.10
Wuerth, J.P.11
Cerami, A.12
Lakatta, E.G.13
-
11
-
-
0032515986
-
Breakers of advanced glycation end products restore large artery properties in experimental diabetes
-
Wolffenbuttel BHR, Boulanger CM, Crijns FRL, Huijberts MSP, Poitevin P, Swennen GNM, Vasan S, Egan JJ, Ulrich P, Cerami A, Levy BI. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc. Natl. Acad. Sci. U.S.A., 95, 4630-4634 (1998).
-
(1998)
Proc. Natl. Acad. Sci. U.S.A.
, vol.95
, pp. 4630-4634
-
-
Wolffenbuttel, B.H.R.1
Boulanger, C.M.2
Crijns, F.R.L.3
Huijberts, M.S.P.4
Poitevin, P.5
Swennen, G.N.M.6
Vasan, S.7
Egan, J.J.8
Ulrich, P.9
Cerami, A.10
Levy, B.I.11
-
12
-
-
79961098801
-
Effect of alagebrium, an advanced glycation endproduct breaker, on exercise tolerence and cardiac funtion in patient with chronic heart failure
-
BENEFICIAL investigators
-
Hartag JW, Willemsen S, van Veldhuisen DJ, Posma JL, van Wijk LM, Hummel YM, Hillege HL, Voovs AA, BENEFICIAL investigators. Effect of alagebrium, an advanced glycation endproduct breaker, on exercise tolerence and cardiac funtion in patient with chronic heart failure. Eur. J. Heart Fail., 13, 899-908 (2011).
-
(2011)
Eur. J. Heart Fail.
, vol.13
, pp. 899-908
-
-
Hartag, J.W.1
Willemsen, S.2
Van Veldhuisen, D.J.3
Posma, J.L.4
Van Wijk, L.M.5
Hummel, Y.M.6
Hillege, H.L.7
Voovs, A.A.8
-
13
-
-
33845969560
-
Health benefits of herbs and spices: The past, the present, the future
-
Tapsell LC, Hemphill I, Cobiac L, Patch CS, Sullivan DR, Fenech M, Roodenrys S, Keogh JB, Clifton PM, Williams PG, Fazio VA, Inge KE. Health benefits of herbs and spices: the past, the present, the future. Med. J. Aust., 185 (Suppl.), S4-S24 (2006).
-
(2006)
Med. J. Aust.
, vol.185
, Issue.SUPPL.
-
-
Tapsell, L.C.1
Hemphill, I.2
Cobiac, L.3
Patch, C.S.4
Sullivan, D.R.5
Fenech, M.6
Roodenrys, S.7
Keogh, J.B.8
Clifton, P.M.9
Williams, P.G.10
Fazio, V.A.11
Inge, K.E.12
-
14
-
-
33847662837
-
Isolation of chebulic acid from Terminalia chebula RETZ. and its antioxidant effect in isolated rat hepatocytes
-
Lee HS, Jung SH, Yun BS, Lee KW. Isolation of chebulic acid from Terminalia chebula RETZ. and its antioxidant effect in isolated rat hepatocytes. Arch. Toxicol., 81, 211-218 (2007).
-
(2007)
Arch. Toxicol.
, vol.81
, pp. 211-218
-
-
Lee, H.S.1
Jung, S.H.2
Yun, B.S.3
Lee, K.W.4
-
15
-
-
0031716747
-
Screening of some Indian medicinal plants for their antimicrobial properties
-
Ahmad I, Mehmood Z, Mohammad F. Screening of some Indian medicinal plants for their antimicrobial properties. J. Ethnopharmacol., 62, 183-193 (1998).
-
(1998)
J. Ethnopharmacol.
, vol.62
, pp. 183-193
-
-
Ahmad, I.1
Mehmood, Z.2
Mohammad, F.3
-
16
-
-
24944516156
-
Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro
-
Lee HS, Won NH, Kim KH, Lee H, Jun W, Lee KW. Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro. Biol. Pharm. Bull., 28, 1639-1644 (2005).
-
(2005)
Biol. Pharm. Bull.
, vol.28
, pp. 1639-1644
-
-
Lee, H.S.1
Won, N.H.2
Kim, K.H.3
Lee, H.4
Jun, W.5
Lee, K.W.6
-
17
-
-
77956647697
-
Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction
-
Lee HS, Koo YC, Suh HJ, Kim KY, Lee KW. Preventive effects of chebulic acid isolated from Terminalia chebula on advanced glycation endproduct-induced endothelial cell dysfunction. J. Ethnopharmacol., 131, 567-574 (2010).
-
(2010)
J. Ethnopharmacol.
, vol.131
, pp. 567-574
-
-
Lee, H.S.1
Koo, Y.C.2
Suh, H.J.3
Kim, K.Y.4
Lee, K.W.5
-
18
-
-
80052672697
-
KIOM-79, an inhibitor of AGEs-protein crosslinking, prevents progression of nephropathy in Zucker diabetic fatty rats
-
Kim YS, Kim J, Kim CS, Sohn EJ, Lee YM, Jeong IH, Kim H, Jang DS, Kim JS. KIOM-79, an inhibitor of AGEs-protein crosslinking, prevents progression of nephropathy in Zucker diabetic fatty rats. Evid.-Based Compl. Alt., 2011, 1-10 (2011).
-
(2011)
Evid.-Based Compl. Alt.
, vol.2011
, pp. 1-10
-
-
Kim, Y.S.1
Kim, J.2
Kim, C.S.3
Sohn, E.J.4
Lee, Y.M.5
Jeong, I.H.6
Kim, H.7
Jang, D.S.8
Kim, J.S.9
-
19
-
-
0014949207
-
Cleavage of structural proteins during assembly of head of bacteriophage T4
-
Laemmli U. Cleavage of structural proteins during assembly of head of bacteriophage T4. Nature, 227, 680-685 (1970).
-
(1970)
Nature
, vol.227
, pp. 680-685
-
-
Laemmli, U.1
-
20
-
-
84857430527
-
Chelation: A fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications
-
Nagai R, Murray DB, Metz TO, Baynes JW. Chelation: A fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications. Diabetes, 61, 549-559 (2012).
-
(2012)
Diabetes
, vol.61
, pp. 549-559
-
-
Nagai, R.1
Murray, D.B.2
Metz, T.O.3
Baynes, J.W.4
-
21
-
-
42049118293
-
The role of advanced glycation end products in progression and complications of diabetes
-
Goh SY, Cooper ME. The role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab., 93, 1143-1152 (2008).
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, pp. 1143-1152
-
-
Goh, S.Y.1
Cooper, M.E.2
-
22
-
-
0035966113
-
Chelating activity of advanced glycation end-product inhibitors
-
Price DL, Rhett PM, Thorpe SR, Baynes JW. Chelating activity of advanced glycation end-product inhibitors. J. Biol. Chem., 276, 48967-48972 (2001).
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 48967-48972
-
-
Price, D.L.1
Rhett, P.M.2
Thorpe, S.R.3
Baynes, J.W.4
-
23
-
-
79959992844
-
Inhibitory effects of Terminalia chebula extract on glycation and endothelial cell adhesion
-
Lee HS, Cho HY, Park KW, Kim IH, Kim JT, Nam MH, Lee KW. Inhibitory effects of Terminalia chebula extract on glycation and endothelial cell adhesion. Planta Med., 77, 1060-1067 (2011).
-
(2011)
Planta Med.
, vol.77
, pp. 1060-1067
-
-
Lee, H.S.1
Cho, H.Y.2
Park, K.W.3
Kim, I.H.4
Kim, J.T.5
Nam, M.H.6
Lee, K.W.7
-
24
-
-
77249139924
-
Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats
-
Nagai R, Nagai M, Shimasaki S, Baynes JW, Fujiwara Y. Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats. Biochem. Biophys. Res. Commun., 393, 118-122 (2010).
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.393
, pp. 118-122
-
-
Nagai, R.1
Nagai, M.2
Shimasaki, S.3
Baynes, J.W.4
Fujiwara, Y.5
|